PharmaLEDA
ActiveSummary
PharmaLEDA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €189,174 and a net result of €59,554. Equity is growing by about 43% per year across the filed financial years. Its solvency ranks better than 29% of 12,404 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Highest result from 2023 to 2025net €59,554 ▲9.8%
Operating result €91,790, net result €59,554, both a record.
31-12
Financial
Equity above €150,000equity €189,174 ▲45%
A profit in every financial year since 2023 builds equity to €189,174.
04-07
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
31-12
Financial
Equity above €100,000equity €130,453 ▲71.1%
A profit in every financial year since 2023 builds equity to €130,453.
02-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.